<IPO>LEADS BIOLABS-B (09887.HK) Priced at Upper Limit HKD35: Report
LEADS BIOLABS-B (09887.HK), a biotechnology company backed by TENCENT, gained traction with the...
LEADS BIOLABS-B (09887.HK), a biotechnology company backed by TENCENT, gained traction with the margin oversubscription reaching 3,028 times, according to data from multiple brokers. The total margin loan amounted to HKD339.84 billion.
Some brokers have already begun notifying clients of allocation results. It is expected that LEADS BIOLABS-B will be priced at HKD35 per share, the upper limit of the offering price range of HKD31.6-35.
LEADS BIOLABS-B will be listed tomorrow (25th), with gray market trading taking place after today's (24th) market close.
(HK stocks quote is delayed for at least 15 mins.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
